Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib (Q46744813)

24 December 2017

title

Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib (English)

1 reference

24 December 2017

protein-losing enteropathy

1 reference

1 reference

1 reference

3

1 reference

24 December 2017

author name string

Ylian S Liem

1

1 reference

24 December 2017

Lars Bode

2

1 reference

24 December 2017

Frank Wg Leebeek

4

1 reference

24 December 2017

Adrienne Am Zandbergen

5

1 reference

24 December 2017

Jh Paul Wilson

6

1 reference

24 December 2017

language of work or name

English

0 references

publication date

19 February 2008

1 reference

24 December 2017

Nature Reviews Gastroenterology & Hepatology

published in

1 reference

24 December 2017

volume

5

1 reference

24 December 2017

page(s)

220-224

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/ncpgasthep1061

exact match

0 references

cites work

Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

Management of protein-losing enteropathy after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNFalpha in inducing barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

Altered glycan structures: the molecular basis of congenital disorders of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis: a new syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

A case of recurrent gastrointestinal bleeding and protein-losing gastroenteropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Heparin therapy and reversal of protein-losing enteropathy in a case with congenital heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP1061

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP1061

1 reference

24 December 2017

PubMed ID

18285818

1 reference

24 December 2017